What’s in news?
- The retail prices of several anti-cancer drugs have been slashed by up to 87% by the drug price control authority.
- The National Pharmaceutical Pricing Authority’s May 15 memorandum has brought nine anti-cancer drugs in its price control framework.
- With an intention to make cancer cure affordable for patients and their families, the retail prices of several anti-cancer drugs, including commonly used chemotherapy injections for lung cancer treatment, have been slashed by up to 87%
by the drug price control authority.
- After reviewing the data collected from drug manufacturers, NPPA’s May 15 memorandum has brought nine anti-cancer drugs in its price control framework.
- The decision is in continuation of the efforts to bring down drugs prices.
- As per the new report, the maximum retail price of chemotherapy injection pemetrexed (500mg), sold under the brand name Pemxcel and used to treat lung cancer, has come down from Rs 22,000 to Rs 2,800. A 100mg dose of the same injection will henceforth cost Rs 800 against Rs 7,700 now.
- And many other costs of the medicines were reduced.
- This is the second time that the NPPA has announced a price cut on anti-cancer drugs since March.
- In February, it invoked an Order, to bring 42 non-scheduled anti-cancer drugs under price control, capping trade margin at 30% through trade margin rationalisation.
- At least 72 formulations and more than 390 brands reduced costs following the order.
- No response raised from, major drug manufacturers on the price cut, health industry spokespersons said the companies have been asked not to cut down on production volumes.
National Pharmaceutical Pricing Authority (NPPA):
- This department Works under the Ministry of Chemicals and Fertilizers.
- Medicines that are not under price control, manufacturers are allowed to increase the maximum retail price by 10% annually.
- The NPPA currently fixes price of drugs on the National List of Essential Medicines under schedule-I of DPCO. So far, around 1,000 drugs have been price-capped through this mode.
- It was established by a Government of India Resolution in 1997.
- It is an office attached to Department of Pharmaceuticals (DoP), Ministry of Chemicals & Fertilizers.
- It is headquartered in New Delhi.
- Function: It is an independent Regulator for pricing of drugs. Ito ensures accessibility and availability of medicines to people at affordable prices.